These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5067774)

  • 1. Melatonin and parkinsonism.
    Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Bell M; Lawrence WH
    JAMA; 1972 Jul; 221(1):88-9. PubMed ID: 5067774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
    De Divitiis E; Cerillo A; Tata MR; Decina A
    Acta Neurol (Napoli); 1973; 28(2):208-12. PubMed ID: 4709076
    [No Abstract]   [Full Text] [Related]  

  • 3. [L-dopa in the treatment of parkinsonism].
    Goldsztajn M; Reichowa J
    Przegl Lek; 1971 Sep; 27(9):592-3. PubMed ID: 4942580
    [No Abstract]   [Full Text] [Related]  

  • 4. L-dopa in the treatment of Parkinsonism.
    Brezný I; Buranová D; Cernácek J; Trávniková M
    Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attempt at treating parkinsonism with L-dopa and Artane].
    Stelmasiak Z; Lackowska H; Maksymowicz B
    Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic modification of Parkinson's disease and of chronic manganese poisoning.
    Cotzias GC; Papavasiliou PS; Ginos J; Steck A; Düby S
    Annu Rev Med; 1971; 22():305-26. PubMed ID: 4944422
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyridoxine, DOPA, and Parkinsonism.
    Yahr MD; Duvoisin RC; Côté L; Cohen G
    Adv Biochem Psychopharmacol; 1972; 4():185-94. PubMed ID: 4555927
    [No Abstract]   [Full Text] [Related]  

  • 8. MK 486 and levodopa in treatment of Parkinsonism.
    Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
    Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
    [No Abstract]   [Full Text] [Related]  

  • 9. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method].
    Okajima T; Kubota A; Nakahara N; Takeda S; Shimomura K
    Naika; 1972; 29(2):335-43. PubMed ID: 4552443
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa].
    Bergamini L; Bonzanino A; Bignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):10-6. PubMed ID: 5524931
    [No Abstract]   [Full Text] [Related]  

  • 13. Melatonin and parkinsonism.
    Shaw KM; Stern GM; Sandler M
    Lancet; 1973 Feb; 1(7797):271. PubMed ID: 4119422
    [No Abstract]   [Full Text] [Related]  

  • 14. [L-dopa treatment of parkinsonism].
    Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewicz E; Wolczyk-Orzechowska M
    Neurol Neurochir Pol; 1973; 7(1):63-8. PubMed ID: 4511385
    [No Abstract]   [Full Text] [Related]  

  • 15. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 16. Pilot study with cyclobenzaprine in idiopathic Parkinsonism.
    Korten JJ; van Hemert J
    Psychiatr Neurol Neurochir; 1973; 76(2):119-28. PubMed ID: 4700930
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-dopa as a substitution for surgery in Parkinsonism?].
    Vladyka V
    Cesk Neurol Neurochir; 1973 Nov; 36(6):337-41. PubMed ID: 4769636
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK
    Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of Parkinson's disease with amantadine and levodopa].
    Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E
    Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa for Parkinson's disease; some limitations in its use.
    Gillen HW
    Med Trial Tech Q; 1973; 19(4):400-8. PubMed ID: 4710961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.